XBI icon

SPDR S&P Biotech ETF

227 hedge funds and large institutions have $3.11B invested in SPDR S&P Biotech ETF in 2016 Q3 according to their latest regulatory filings, with 49 funds opening new positions, 70 increasing their positions, 60 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding in top 10

Funds holding in top 10:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

13% more funds holding

Funds holding: 201227 (+26)

6.53% more ownership

Funds ownership: 112.16%118.69% (+6.5%)

31% less call options, than puts

Call options by funds: $724M | Put options by funds: $1.04B

Holders
227
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$724M
Puts
$1.04B
Net Calls
Net Calls Change

Top Buyers

1 +$166M
2 +$99.4M
3 +$83.3M
4
Barclays
Barclays
United Kingdom
+$40.6M
5
Morgan Stanley
Morgan Stanley
New York
+$38.9M

Top Sellers

1 -$108M
2 -$49.5M
3 -$40.3M
4
RG
Redmile Group
California
-$26.6M
5
Rafferty Asset Management
Rafferty Asset Management
New York
-$17.1M
Name Holding Trade Value Shares
Change
Change in
Stake
101
$984K
102
$977K
103
$938K
104
$908K
105
$907K
106
$877K
107
$852K
108
$836K
109
$802K
110
$796K
111
$780K
112
$777K
113
$747K
114
$729K
115
$729K
116
$726K
117
$725K
118
$722K
119
$696K
120
$689K
121
$668K
122
$663K
123
$651K
124
$603K
125
$595K